VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW
posted
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Devgen nv (Euronext Brussels: DEVG), announced today its results for the six month period ending 30 June 2011. read more
Ablynx [Euronext Brussels: ABLX] today announced its results for the six-month period ending 30 June 2011, which have been prepared in accordance with the IAS 34 Interim Financial Reporting as adopted by the European Union, and highlighted the developments in its product pipeline and partnerships. read more
TiGenix NV (NYSE Euronext: TIG) gives an update of its business activities and provides the financial highlights for the half year ending June 30, 2011. read more
Clinici beschikken voortaan over een nieuw hulpmiddel bij het stellen van een diagnose en het behandelen van patiënten besmet met het Herpes simplex-virus (HSV) – één van de meest gangbare seksueel overdraagbare aandoeningen ter wereld. read more
BD Biosciences, een onderdeel van BD (Becton, Dickinson and Company), heeft vandaag de BD FACSVerse™-flowcytometer geïntroduceerd. Dit is een flexibel, betrouwbaar en schaalbaar systeem dat maximaal 10 parameters kan analyseren en voor een groot aantal onderzoekstoepassingen kan worden gebruikt. read more
MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results. read more
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on ophthalmic medicine, today issued a business update and its financial results for the six months ending 30 June, 2011. read more
Pharmaneuroboost (PNB) reported today that it received clearance from the Institutional Review Board (IRB) to initiate its first phase III study with PNB01 in the USA. read more
Two main agents involved in the inception of Alzheimer's disease (APP and beta secretase) follow a different path through the brain cells to meet up, write Wim Annaert and colleagues of VIB and K.U.Leuven in PNAS. read more
